02:44 PM EDT, 07/31/2026 (MT Newswires) -- (Updates with share moves in first paragraph.)

Guardant Health ( GH ) shares were up more than 6% in Friday trading following its Q2 results in the previous day.

Late Thursday, the company reported an adjusted loss of $0.42 per diluted share, compared with a loss of $0.44 a year earlier.

Analysts polled by FactSet expected a loss of $0.39.

Revenue for the quarter ended June 30 was $335.0 million, up from $232.1 million a year ago.

Analysts expected $314.2 million.

The company now expects full year 2026 revenue to be between $1.34 billion and $1.36 billion, up from $1.30 billion to $1.32 billion previously. Analysts expect $1.31 billion.

Price: 161.93, Change: +9.58, Percent Change: +6.29